<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Osteoporos Int</journal-id><journal-id journal-id-type="iso-abbrev">Osteoporos Int</journal-id><journal-title-group><journal-title>Osteoporosis International</journal-title></journal-title-group><issn pub-type="ppub">0937-941X</issn><issn pub-type="epub">1433-2965</issn><publisher><publisher-name>Springer London</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4643543</article-id><article-id pub-id-type="publisher-id">2863</article-id><article-id pub-id-type="doi">10.1007/s00198-014-2863-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Sakai</surname><given-names>A.</given-names></name><address><email>a-sakai@med.uoeh-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Okimoto</surname><given-names>N.</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>H.</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Teshima</surname><given-names>K.</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Okazaki</surname><given-names>Y.</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Fukuda</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Arita</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Tsurukami</surname><given-names>H.</given-names></name><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Nagashima</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Yoshioka</surname><given-names>T.</given-names></name><xref ref-type="aff" rid="Aff11"/></contrib><aff id="Aff1"><label/>Department of Orthopaedic Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555 Japan </aff><aff id="Aff2"><label/>Department of Orthopaedic Surgery, Ken-Ai Memorial Hospital, Onga, Japan </aff><aff id="Aff3"><label/>Okimoto Clinic, Kure, Japan, Okamoto Orthopaedics and Sports Clinic, Hiroshima, Japan </aff><aff id="Aff4"><label/>Department of Orthopaedic Surgery, Sanzai Hospital, Saito, Japan </aff><aff id="Aff5"><label/>Teshima Orthopaedic Clinic, Kitakyushu, Japan </aff><aff id="Aff6"><label/>Department of Orthopaedic Surgery, Makiyama Central Hospital, Fukuoka, Japan </aff><aff id="Aff7"><label/>Department of Orthopaedic Surgery, Kitakyushu General Hospital, Kitakyushu, Japan </aff><aff id="Aff8"><label/>Department of Orthopaedic Surgery, Obase Hospital, Miyako, Japan </aff><aff id="Aff9"><label/>Tsurukami Clinic of Orthopaedic and Rheumatology, Kumamoto, Japan </aff><aff id="Aff10"><label/>Katsuki Neurosurgery and Orthopaedic Clinic, Nogata, Japan </aff><aff id="Aff11"><label/>Department of Orthopaedic Surgery, Sakamidorii Hospital, Hiroshima, Japan </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>8</month><year>2014</year></pub-date><pub-date pub-type="ppub"><year>2014</year></pub-date><volume>25</volume><issue>10</issue><fpage>2505</fpage><lpage>2506</lpage><permissions><copyright-statement>&#x000a9; International Osteoporosis Foundation and National Osteoporosis Foundation 2014</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d30e87" ext-link-type="doi" xlink:href="10.1007/s00198-014-2756-8"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; International Osteoporosis Foundation and National Osteoporosis Foundation 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p><bold>Erratum to: Osteoporos Int</bold></p><p><bold>DOI 10.1007/s00198-014-2756-8</bold></p><p>In the second paragraph of the Introduction section, the last portion of the first sentence states: &#x0201c;&#x02026; and approved for use for the treatment of osteoporosis in Japan [11].&#x0201d; This was inadequately referenced, and should be &#x0201c;approved for use for the treatment of osteoporosis in Japan [11, 17&#x02013;19].&#x0201d;</p><p>In the fourth paragraph of the Discussion section, the first portion of the first sentence states: &#x0201c;While many reports have indicated the bone density-increasing effects of switching to daily minodronate from other BPs [11, 17&#x02013;19], &#x02026;&#x0201d; This was incorrectly referenced, and should be &#x0201c;While many reports have indicated the bone density-increasing effects of switching to daily minodronate from other BPs [23&#x02013;25], &#x02026;&#x0201d;</p><p>In the fifth paragraph of the Discussion section, the first portion of the first sentence states: &#x0201c;While daily minodronate has been reported to alleviate low back pain [19], &#x02026;&#x0201d;. Additionally, in the sixth paragraph of the Discussion section, the first sentence states: &#x0201c;We have already reported that daily minodronate treatment induced fewer GI symptoms in comparison with weekly alendronate treatment [19].&#x0201d; The reference number [19] is incorrect and should be [18] in both cases.</p><p>An inappropriate publication was cited as reference 21. The correct reference is:</p><p>21. Nozaki K, Kakimoto S, Kimoto A, Yoshino T, Sato Y, Yoshida A, Nakamura T (2011) Investigation into the analgesic effects of minodronic acid hydrate via P2X<sub>2/3</sub> receptor (in Japanese). Shinyaku To Rinsho (J New Rem Clin) 60(9):1766&#x02013;1774</p><p>The following three publications should have been included in the References section.</p><p>23. Shimoda J (2010) Clinical experience with minodronate for the treatment of osteoporosis unresponsive to alendronate therapy (in Japanese). Osteoporosis Jpn 18(4):739&#x02013;744</p><p>24. Kogawa R, Takagi H (2011) Clinical efficacy of minodronic acid hydrate, a newly developed bisphosphonate, in osteoporotic patients who responded poorly to alendronate therapy (in Japanese). Osteoporosis Jpn 19(4):725&#x02013;734</p><p>25. Matsui H (2012) Clinical effects of minodronic acid hydrate in patients with postmenopausal osteoporosis who underwent first bisphosphonate therapy or pretreatment with risedronate (in Japanese). Central Japan Association of Orthopaedic Surgery &#x00026; Traumatology 55(3):531&#x02013;532</p></body><back><fn-group><fn><p>The online version of the original article can be found at 10.1007/s00198-014-2756-8.</p></fn></fn-group></back></article>